PBA
KRTX

Paradigm Biocapital Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Paradigm Biocapital Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-283,605
Closed -$61.5M – 35
2023
Q2 		$61.5M Buy
+283,605
New +$61.5M 4.75% 5
2023
Q1 		– Sell
-106,210
Closed -$20.9M – 29
2022
Q4 		$20.9M Buy
+106,210
New +$20.9M 2.45% 17